EGFR and colorectal carcinoma: Therefore, we aimed to profile CRC tissues to investigate the correlation between mutational status and various receptor tyrosine kinase (RTK) protein expressions such as HER1, HER2, HER3, c-MET, and insulin-like growth factor 1 receptor (IGF1R).